Your browser doesn't support javascript.
loading
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
Gaglani, Manjusha; Kim, Sara S; Naleway, Allison L; Levine, Min Z; Edwards, Laura; Murthy, Kempapura; Dunnigan, Kayan; Zunie, Tnelda; Groom, Holly; Ball, Sarah; Jeddy, Zuha; Hunt, Danielle; Wesley, Meredith G; Sambhara, Suryaprakash; Gangappa, Shivaprakash; Grant, Lauren; Cao, Weiping; Gross, F Liaini; Mishina, Margarita; Fry, Alicia M; Thompson, Mark G; Dawood, Fatimah S; Flannery, Brendan.
Afiliación
  • Gaglani M; Department of Pediatrics, Baylor Scott & White Health, Temple, Texas, USA.
  • Kim SS; Department of Medical Education, Texas A & M University College of Medicine, Temple, Texas, USA.
  • Naleway AL; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Levine MZ; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Edwards L; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Murthy K; Abt Associates, Atlanta, Georgia, USA.
  • Dunnigan K; Department of Pediatrics, Baylor Scott & White Health, Temple, Texas, USA.
  • Zunie T; Department of Pediatrics, Baylor Scott & White Health, Temple, Texas, USA.
  • Groom H; Department of Pediatrics, Baylor Scott & White Health, Temple, Texas, USA.
  • Ball S; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
  • Jeddy Z; Abt Associates, Atlanta, Georgia, USA.
  • Hunt D; Abt Associates, Atlanta, Georgia, USA.
  • Wesley MG; Abt Associates, Atlanta, Georgia, USA.
  • Sambhara S; Abt Associates, Atlanta, Georgia, USA.
  • Gangappa S; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Grant L; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Cao W; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Gross FL; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Mishina M; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Fry AM; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Thompson MG; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Dawood FS; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Flannery B; Influenza Division of the National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Clin Infect Dis ; 76(3): e1168-e1176, 2023 02 08.
Article en En | MEDLINE | ID: mdl-36031405

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacuna contra Viruela / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Tipo de estudio: Clinical_trials Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Vacuna contra Viruela / Gripe Humana / Subtipo H1N1 del Virus de la Influenza A Tipo de estudio: Clinical_trials Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos